Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab plus irinotecan and 5-FU/leucovorin in metastatic gastric cancer
2006-000208-17Phase 2Completed
- Sponsor
- University Medical Center Mainz
- Start
- Mar 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cetuximab in gastric adenocarcinoma, sponsored by University Medical Center Mainz. Primary endpoint: Objective response rate. Started Mar 2006; status: completed.
02
Drugs
cetuximab
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on 2006-000208-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000208-17.